Cell Reports
(May 2017)
Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development
Elena Campos-Sanchez,
Nerea Deleyto-Seldas,
Veronica Dominguez,
Enrique Carrillo-de-Santa-Pau,
Kiyoe Ura,
Pedro P. Rocha,
JungHyun Kim,
Arafat Aljoufi,
Anna Esteve-Codina,
Marc Dabad,
Marta Gut,
Holger Heyn,
Yasufumi Kaneda,
Keisuke Nimura,
Jane A. Skok,
Maria Luisa Martinez-Frias,
Cesar Cobaleda
Affiliations
Elena Campos-Sanchez
Department of Cell Biology and Immunology, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC/UAM, Madrid 28049, Spain
Nerea Deleyto-Seldas
Department of Cell Biology and Immunology, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC/UAM, Madrid 28049, Spain
Veronica Dominguez
Transgenesis Service CNB-CBMSO CSIC/UAM, Madrid 28049, Spain
Enrique Carrillo-de-Santa-Pau
Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain
Kiyoe Ura
Department of Biology, Graduate School of Science, Chiba University, Yayoicho, Inage-ku, Chiba 263-8522, Japan
Pedro P. Rocha
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
JungHyun Kim
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
Arafat Aljoufi
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
Anna Esteve-Codina
CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain
Marc Dabad
CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain
Marta Gut
CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain
Holger Heyn
CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain
Yasufumi Kaneda
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Yamada-oka, Suita, Osaka 565-0871, Japan
Keisuke Nimura
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Yamada-oka, Suita, Osaka 565-0871, Japan
Jane A. Skok
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
Maria Luisa Martinez-Frias
ECEMC (Spanish Collaborative Study of Congenital Malformations), Madrid 28029, Spain
Cesar Cobaleda
Department of Cell Biology and Immunology, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC/UAM, Madrid 28049, Spain
DOI
https://doi.org/10.1016/j.celrep.2017.04.069
Journal volume & issue
Vol. 19,
no. 8
pp.
1586
– 1601
Abstract
Read online
Immunodeficiency is one of the most important causes of mortality associated with Wolf-Hirschhorn syndrome (WHS), a severe rare disease originated by a deletion in chromosome 4p. The WHS candidate 1 (WHSC1) gene has been proposed as one of the main genes responsible for many of the alterations in WHS, but its mechanism of action is still unknown. Here, we present in vivo genetic evidence showing that Whsc1 plays an important role at several points of hematopoietic development. Particularly, our results demonstrate that both differentiation and function of Whsc1-deficient B cells are impaired at several key developmental stages due to profound molecular defects affecting B cell lineage specification, commitment, fitness, and proliferation, demonstrating a causal role for WHSC1 in the immunodeficiency of WHS patients.
Keywords
WeChat QR code
Close